Related Experiment Video
Updated: Jul 5, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Lipopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2)
Tsuyoshi Tajima1, Takahisa Murata, Kosuke Aritake
1Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The University of Tokyo, Tokyo, Japan.
Abstract:
Lipopolysaccharide (LPS) produces prostaglandins (PGs) concomitant to eliciting macrophage migration. We evaluated the role of PGs in initiating the migration of macrophages, especially focusing on PGD(2) and PGE(2). In RAW264.7 macrophages, cyclooxygenase (COX)-2 inhibitor, CAY10404 [3-(4-methylsulphonylphenyl)-4-phenyl-5-trifluoromethylisoxazole], completely inhibited LPS-mediated migration at 4 h (early phase) but only partially inhibited the migration at 8 h (late phase), suggesting the presence of PG-dependent and -independent pathways. In the early phase, LPS up-regulated mRNA expressions of COX-2, hematopoietic PGD synthase (H-PGDS), and microsomal-PGE synthase 1, increasing PGD(2) and PGE(2) substantially. The chemoattractant receptor-homologous molecule expressed on Th2 lymphocytes (CRTH2) agonist, DK-PGD(2) (13-14-dihydro-15-keto-PGD(2)), and the EP4 agonist, ONO-AE1-329 (16-{3-methoxymethyl}phenyl-omega-tetranor-3,7-dithia-prostaglandin E(1)), but not selective agonists of D prostanoid receptor, E prostanoid receptor (EP) 2, or EP3, stimulated random migration (chemokinesis). In peritoneal macrophages from CRTH2-deficient and H-PGDS-deficient mice, LPS-mediated migration was significantly inhibited at either early or late phases of the migration. The H-PGDS inhibitor, HQL-79 [4-(diphenylmethoxy)-1-[3-(1H-tetrazol-5-yl)propyl-piperidine]], partially inhibited the migration of the RAW264.7 macrophage in both phases. These results suggest the importance of the PGD(2)/CRTH2 pathway in LPS-mediated migration of macrophages. In the late phase of migration, LPS up-regulated monocyte chemoattractant protein (MCP)-1 mRNA. The CC chemokine receptor (CCR2) antagonist, RS102895 [1'-[2-[4-(trifluoromethyl)phenyl]ethyl]-spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one], inhibited LPS-mediated migration in the late phase without affecting the early phase. ONO-AE1-329, but not DK-PGD(2), up-regulated MCP-1 mRNA. Taken together, LPS stimulation of chemokinesis or chemotaxis, or both, occurs in macrophages via PGD(2) and PGE(2) in tandem arrangement; i.e., 1) LPS stimulates prostaglandin signaling, initiating early migration through the PGD(2)/CRTH2 and PGE(2)/EP4 signaling pathways; and 2) LPS leads induction of MCP-1, which contributes to later phase migration of the macrophages through the PGE(2)/EP4 pathway.
Insights
Lipopolysaccharide (LPS) triggers macrophage migration through prostaglandin (PG) signaling. Early migration relies on PGD(2)/CRTH2 and PGE(2)/EP4 pathways, while later migration involves MCP-1 induction via PGE(2)/EP4 signaling.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Lipopolysaccharide (LPS) is a potent immune activator known to induce prostaglandin (PG) production and macrophage migration.
- Prostaglandins, particularly PGD(2) and PGE(2), are implicated in inflammatory responses and cell movement, but their precise roles in LPS-mediated macrophage migration require further elucidation.
Purpose of the Study:
- To investigate the specific roles of prostaglandin D2 (PGD(2)) and prostaglandin E2 (PGE(2)) in initiating and regulating lipopolysaccharide (LPS)-induced macrophage migration.
- To differentiate between early and late phase mechanisms of LPS-mediated macrophage migration, focusing on prostaglandin-dependent and -independent pathways.
Main Methods:
- Utilized RAW264.7 macrophages and primary peritoneal macrophages from wild-type and knockout mice (CRTH2-deficient, H-PGDS-deficient).
- Employed cyclooxygenase (COX)-2 inhibitors (CAY10404), prostaglandin synthase inhibitors (HQL-79), and specific receptor agonists (DK-PGD(2), ONO-AE1-329) and antagonists (RS102895).
- Assessed macrophage migration (chemokinesis and chemotaxis) and quantified mRNA expression of key inflammatory mediators (COX-2, H-PGDS, microsomal-PGE synthase 1, MCP-1) using quantitative PCR.
Main Results:
- LPS-induced macrophage migration occurred in distinct early (PG-dependent) and late (PG-independent/dependent) phases.
- Early migration was significantly inhibited by a COX-2 inhibitor and involved up-regulation of PGD(2) and PGE(2) synthesis.
- PGD(2)/CRTH2 and PGE(2)/EP4 pathways mediated early migration (chemokinesis), while PGE(2)/EP4 signaling also induced MCP-1, contributing to late-phase migration (chemotaxis).
Conclusions:
- LPS-mediated macrophage migration is a complex process involving sequential prostaglandin signaling pathways.
- The PGD(2)/CRTH2 axis is crucial for the initial phase of LPS-induced macrophage migration.
- PGE(2)/EP4 signaling plays a dual role, promoting early migration and later inducing MCP-1 for sustained chemotaxis.
Related Concept Videos
Formation of Lipopolysaccharides
IP3/DAG Signaling Pathway

